Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "quest diagnostics"

Next Resistance Level for Quest Diagnostics (DGX) is $77.54

Shares of Quest Diagnostics (NYSE:DGX) opened today above their pivot of $76.44 and have already reached the first level of resistance at $77.14. Investors may be interested in a cross of the next upside pivot targets of $77.54, 5 days ago

32 images for quest diagnostics

Quest Diagnostics, 1 week ago
PR Newswire, 6 days ago
Njbiz, 1 week ago
American Banking News, 2 weeks ago
Yahoo! Finance, 3 weeks ago, 5 days ago, 5 days ago
Njbiz, 3 weeks ago
KXXV-TV, 3 weeks ago
Kansas City Business Journal, 3 weeks ago

BUYINS.NET: DGX, IWD, VO, JKE, PXR, AVA Are Seasonally Ripe To Go Up In the Next Five Weeks

BUYINS.NET / is monitoring the Seasonality of QUEST DIAGNOSTICS INCORPORATED (NYSE:DGX), Ishares Trust Russell (NYSE:IWD), Vanguard Mid Cap ETF (NYSE:VO), iShares Morningstar Large Growth Index Fund (NYSE:JKE), Prominex ...
 Individual.com4 days ago

Has Quest Diagnostics Rediscovered Its Touch?

Mar. 23, 2015 1:54 PM ET | About: Quest Diagnostics Incorporated (DGX), Includes: LH, MYGN by: Brian Wu Summary Shares of Quest Diagnostics have performed well over the last 12 months after badly lagging the industry over the past five years.
 Seeking Alpha4 days ago

Vermillion Reports Fourth Quarter and Full Year 2014 Results

"We are very pleased to have completed our new commercial agreement with Quest Diagnostics as well as increase the market in which we offer ASPiRA Labs' OVA1 testing service," stated Valerie Palmieri , President and CEO of Vermillion, Inc. Key ...
 Morningstar.com4 days ago Vermillion and Quest sign commercialization agreement for ovarian cancer test  Individual.com6 days ago Vermillion inks new commercialization & services agreement with Quest Diagnostics  PharmaBiz1 week ago Vermillion and Quest Diagnostics Announce New Commercial Agreement  Nasdaq1 week ago

First Week of November 20th Options Trading For Quest Diagnostics (DGX)

Investors in Quest Diagnostics, Inc. ( NYSE: DGX ) saw new options begin trading this week, for the November 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days ...
 Forbes.com5 days ago
Wall Street Business Network

QUEST DIAGNOSTICS : Announces Early Tender Date Results of Cash Tender Offers for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes

/PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today the early tender results of its previously announced cash tender offers (each, an "Offer" and, collectively, ...
 4 Traders1 week ago Quest Diagnostics Prices Up to $250M Notes  Citybizlist1 week ago Quest Diagnostics Announces Pricing of Cash Tender Offers for Up to $250 Million Combined Aggregate Principal Amount of Certain of its Outstanding Notes  Wall Street Business Network1 week ago Quest Diagnostics announces availability of new whole exome sequencing service  Individual.com1 week ago

Quest Diagnostics India Launches Satellite Pathology Laboratory in Ghaziabad

Zee Media Bureau Gh Ghaziabad: Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Quest Diagnostics is America's leading provider of ...
 ZeeNews.com2 weeks ago

As Quest Diagnostics' good times continue, company is refreshing its brand [Pittsburgh Post-Gazette]

March 18--After a year that saw its stock price hit all-time highs and Fortune magazine name it a "most admired company" in the pharmacy and other health care services category, Quest Diagnostics But it's not standing pat, says president and CEO ...
 BusinessWeek1 week ago
American Banking News

Analyst Rating In Review: Quest Diagnostics Bid Up 0.3% Since Upgraded 7 Days Ago (DGX)

(Financial News Network On) Quest Diagnostics was upgraded from Hold to Buy by Canaccord Genuity one week ago. Quest Diagnostics stocks closed at $71.09, a 0.3% gain over the course of one week. Potential upside of 2.2% exists for Quest ...
 Individual.com2 weeks ago Quest Diagnostics Upgraded at Canaccord Genuity (DGX)  SleekMoney3 weeks ago Quest Diagnostics Stock Rating Upgraded by Canaccord Genuity (DGX)  American Banking News3 weeks ago Quest Diagnostics Cut to Buy at Goldman Sachs (DGX)  SleekMoney3 weeks ago

Shares of Quest Diagnostics Rise Above...

Shares of Quest Diagnostics (NYSE:DGX) traded at a new 52-week high today of $74.43. Approximately 831,000 shares have changed hands today, as compared to an average 30-day volume of 1.5 million shares. In the past 52 weeks, shares of Quest ...
 Financial News Network online1 week ago Quest Diagnostics Shares Climbing Higher, Up 2.2%  Individual.com2 weeks ago Shares of DGX Up 27.8% Since Uptrend Call on Shares  Individual.com5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - quest diagnostics
Get updated on latest news & your favorite topics right in your inbox!
More     Less